Φορτώνει......
Neoadjuvant therapy for pancreatic ductal adenocarcinoma: Opportunities for personalized cancer care
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy that is best treated in a multidisciplinary fashion using surgery, chemotherapy, and radiation. Adjuvant chemotherapy has shown to have a significant survival benefit in patients with resected PDAC. However, up to 50% of patients fa...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | World J Gastroenterol |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Baishideng Publishing Group Inc
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8316910/ https://ncbi.nlm.nih.gov/pubmed/34366611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v27.i27.4383 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|